NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Operating income, 2025
- DKK 127.7B
- YoY, 2025
- −0.5%
- 5-year CAGR
- +18.7%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | DKK 127.7B | −0.5% |
| 2024 | DKK 128.3B | +25.1% |
| 2023 | DKK 102.6B | +37.1% |
| 2022 | DKK 74.8B | +27.6% |
| 2021 | DKK 58.6B | +8.3% |
| 2020 | DKK 54.1B | +3.1% |
| 2019 | DKK 52.5B | — |